[Federal Register Volume 86, Number 17 (Thursday, January 28, 2021)]
[Notices]
[Pages 7402-7403]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01879]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the Advisory Committee on Childhood Vaccines

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Advisory Committee on Childhood Vaccines 
(ACCV) will hold public meetings for the 2021 calendar year (CY). 
Information about the ACCV, agendas, and materials for these meetings 
can be found on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines.

DATES: ACCV meetings will be held on:
    <bullet> March 4, 2021, 10:00 a.m. Eastern Time (ET)-4:00 p.m. ET;
    <bullet> June 3, 2021, 10:00 a.m. ET-4:00 p.m. ET;
    <bullet> September 2, 2021, 10:00 a.m. ET-4:00 p.m. ET;
    <bullet> December 2, 2021, 10:00 a.m. ET-4:00 p.m. ET.

ADDRESSES: Meetings may be held in-person or by teleconference and 
webinar. For updates on how the meeting will be held, visit the ACCV 
website 30 business days before the date of the meeting, where 
instructions for joining meetings either in-person and remotely will 
also be posted. In-person ACCV meetings will be held at 5600 Fishers 
Lane, Rockville, Maryland 20857. For meeting information updates, go to 
the ACCV website listed above.

FOR FURTHER INFORMATION CONTACT: Annie Herzog, Division of Injury 
Compensation Programs, HRSA, 5600 Fishers Lane, Rockville, Maryland 
20857; 301-443-6634; or <a href="/cdn-cgi/l/email-protection#8acbc9c9dccac2d8d9cba4ede5fc"><span class="__cf_email__" data-cfemail="3b7a78786d7b7369687a155c544d">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations 
to the Secretary of HHS on policy, program development, and other 
issues related to implementation of the National Vaccine Injury 
Compensation Program (VICP) and concerning other matters as described 
under section 2119 of the Public Health Service Act (42 U.S.C. 300aa-
19).
    Since priorities dictate meeting times, be advised that times and 
agenda items are subject to change. Refer to the ACCV website listed 
above for any meeting updates that may occur. For CY 2021 meetings, 
agenda items may include, but are not limited to updates from the 
Division of Injury Compensation Programs, Department of Justice, Office 
of Infectious Disease and HIV/AIDS Policy (HHS), Immunization Safety 
Office (Centers for Disease Control and Prevention), National Institute 
of Allergy and Infectious Diseases (National Institutes of Health) and 
Center for Biologics, Evaluation and Research (Food and Drug 
Administration). Refer to the ACCV website listed above for all current 
and updated information concerning the CY 2021 ACCV meetings, including 
draft agendas and meeting materials that will be posted 5 calendar days 
before the meeting(s).
    Members of the public will have the opportunity to provide 
comments.

[[Page 7403]]

Public participants may submit written statements in advance of the 
scheduled meeting(s). Oral comments will be honored in the order they 
are requested and may be limited as time allows. Requests to submit a 
written statement or make oral comments to ACCV should be sent to Annie 
Herzog using the contact information above at least 5 business days 
before the meeting date(s).
    Individuals who need special assistance or another reasonable 
accommodation should notify Annie Herzog using the contact information 
listed above at least 10 business days before the meeting(s) they wish 
to attend.
    If an in-person meeting is held, it will occur in a federal 
government building and all attendees must go through a security check 
to enter. Non-U.S. Citizen attendees must notify HRSA of their planned 
attendance to an in-person meeting at least 20 business days prior to 
the meeting in order to facilitate their entry into the building. All 
attendees are required to present government-issued identification 
prior to entry.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021-01879 Filed 1-27-21; 8:45 am]
BILLING CODE 4165-15-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>